Kraig Biocraft Laboratories, Inc (KBLB) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2723 SOUTH STATE STREET ANN ARBOR, MI 48104 |
| State of Incorp. | WY |
| Fiscal Year End | December 31 |
| Industry (SIC) | 282 - Plastics Materials And Synthetic Resins, Synthetic (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,552 | 3,863 | 2,355 | 817 | 125 | 14 | |||
| Cash and cash equivalents | 2,552 | 3,863 | 2,355 | 817 | 125 | 14 | |||
| Inventory, net of allowances, customer advances and progress billings | 7 | 7 | |||||||
| Inventory | 7 | 7 | |||||||
| Prepaid expense | 15 | 16 | 11 | 3 | 32 | 7 | |||
| Deposits current assets | 98 | ||||||||
| Total current assets: | 2,574 | 3,983 | 2,366 | 819 | 157 | 21 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 96 | 59 | 104 | 365 | 473 | ✕ | |||
| Property, plant and equipment | 67 | 88 | 111 | 89 | 117 | 47 | |||
| Long-term investments and receivables | 493 | 437 | 437 | ||||||
| Long-term investments | 493 | 437 | 437 | ||||||
| Other undisclosed noncurrent assets | 4 | 4 | 4 | 4 | 4 | 4 | |||
| Total noncurrent assets: | 659 | 587 | 656 | 458 | 594 | 51 | |||
| TOTAL ASSETS: | 3,233 | 4,571 | 3,022 | 1,277 | 751 | 71 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 56 | 540 | 588 | 600 | 561 | 793 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 32 | |||||
| Accrued liabilities | 56 | 108 | 65 | 65 | 65 | 65 | |||
| Other undisclosed accounts payable and accrued liabilities | 432 | 491 | 535 | 496 | 728 | ||||
| Debt | 35 | 95 | 563 | 111 | 171 | 322 | |||
| Due to related parties | ✕ | ✕ | 7,332 | 6,902 | 1,657 | 4,145 | 248 | ||
| Other undisclosed current liabilities | 8,794 | 104 | 110 | 5,083 | 707 | 3,167 | |||
| Total current liabilities: | 8,886 | 8,072 | 8,163 | 7,451 | 5,584 | 4,531 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 155 | 400 | 555 | ||||||
| Long-term debt, excluding current maturities | 95 | 145 | 185 | ||||||
| Liabilities, other than long-term debt | 54 | 21 | |||||||
| Operating lease, liability | 54 | 21 | 60 | 255 | 369 | ✕ | |||
| Other undisclosed noncurrent liabilities | (60) | (255) | |||||||
| Total noncurrent liabilities: | 54 | 21 | 155 | 400 | 555 | ||||
| Total liabilities: | 8,940 | 8,093 | 8,318 | 7,851 | 6,139 | 4,531 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (5,707) | (3,522) | (5,296) | (6,574) | (5,388) | (4,459) | |||
| Preferred stock | 5,218 | 5,218 | |||||||
| Common stock | 22 | ||||||||
| Additional paid in capital | 11,354 | 10,835 | 9,894 | 5,834 | 2,413 | 2,043 | |||
| Accumulated deficit | (49,687) | (46,657) | (42,815) | (34,769) | (29,798) | (26,888) | |||
| Other undisclosed equity, attributable to parent | 32,625 | 32,300 | 27,625 | 22,362 | 16,779 | 15,146 | |||
| Total equity: | (5,707) | (3,522) | (5,296) | (6,574) | (5,388) | (4,459) | |||
| TOTAL LIABILITIES AND EQUITY: | 3,233 | 4,571 | 3,022 | 1,277 | 751 | 71 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 110 | 402 | ||||||
| Net investment income | 110 | |||||||
| Gross profit: | 110 | 402 | ||||||
| Operating expenses | (2,615) | (2,121) | (2,760) | (4,534) | (2,622) | (1,362) | ||
| Other undisclosed operating loss | (110) | |||||||
| Operating loss: | (2,615) | (2,121) | (2,760) | (4,534) | (2,622) | (960) | ||
| Nonoperating expense | (415) | (1,721) | (5,286) | (437) | (288) | (209) | ||
| Interest and debt expense | (154) | (238) | (5) | (294) | 20 | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (20) | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (3,030) | (3,996) | (8,284) | (4,977) | (3,204) | (1,169) | ||
| Other undisclosed income from continuing operations before income taxes | 154 | 238 | 5 | 294 | ||||
| Loss from continuing operations: | (3,030) | (3,842) | (8,046) | (4,971) | (2,910) | (1,169) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (8,046) | (4,971) | (2,910) | (1,169) | |
| Net loss available to common stockholders, diluted: | (3,030) | (3,842) | (8,046) | (4,971) | (2,910) | (1,169) | ||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (3,030) | (3,842) | (8,046) | (4,971) | (2,910) | (1,169) | ||
| Comprehensive loss, net of tax, attributable to parent: | (3,030) | (3,842) | (8,046) | (4,971) | (2,910) | (1,169) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.